Get access

Adverse drug reactions: treatment burdens and nurse-led medication monitoring

Authors

  • MARIE E. GABE BN (Hons), BSc (Hons), RN,

    1. Research Capacity Building Collaboration (RCBC) Wales PhD fellow, College of Human and Health Sciences, Swansea University, Swansea
    Search for more papers by this author
  • GWYNETH A. DAVIES MD, MRCP, MB BCh,

    1. Clinical Senior Lecturer, College of Medicine, Swansea University, Swansea and Honorary Respiratory Consultant, Abertawe Bro Morgannwg University Health Board
    Search for more papers by this author
  • FIONA MURPHY PhD, MSc, BN, RGN, HV, NDN, PGCE(FE), RCNT,

    1. Senior Lecturer, College of Human and Health Sciences, Swansea University, Swansea
    Search for more papers by this author
  • MICHELLE DAVIES BN, RN,

    1. Respiratory Nurse Specialist, Respiratory Medicine, Singleton Hospital, Abertawe Bro Morgannwg University Health Board
    Search for more papers by this author
  • LINZI JOHNSTONE RN,

    1. Respiratory Nurse Specialist, Respiratory Medicine, Singleton Hospital, Abertawe Bro Morgannwg University Health Board
    Search for more papers by this author
  • SUE JORDAN MB BCh, PhD PGCE (FE)

    1. Reader, College of Human and Health Sciences, Swansea University, Swansea, Wales, UK
    Search for more papers by this author

Marie Gabe
Research Capacity Building Collaboration (RCBC) Wales
Room 235 Vivian Tower
College of Human and Health Sciences
Swansea University
Singleton Park
Swansea
SA2 8PP.
Wales
UK
E-mail: 446259@swansea.ac.uk

Abstract

Gabe M.E., Davies G.A., Murphy F., Davies M., Johnstone L. & Jordan S. (2011) Journal of Nursing Management 19, 377–392
Adverse drug reactions: treatment burdens and nurse-led medication monitoring

Aim  This paper focuses on adverse drug reactions and the potential for introduction of nurse-led medication monitoring.

Background  The prevention of patient harm caused by health-care organizations was accorded international priority over a decade ago, yet adverse drug reactions remain a significant treatment burden to patients.

Evaluation  This paper reviews the literature to summarize existing knowledge and understand treatment burdens associated with adverse drug reactions.

Key issues  While epidemiological studies explore the magnitude and complex nature of adverse incidents in health-care organizations, the monitoring of prescribed medications and their adverse effects remains an area of concern. Nurse-led medication monitoring has been highlighted as an initiative to minimize unnecessary drug-related patient harm.

Conclusion  This paper indicates that nurses are well-placed to monitor and reduce drug-related morbidity, and builds upon previous work which prioritizes the monitoring of prescribed medicine in a nurse-led adverse drug reaction profile.

Implications for nursing management  Nurse-led medication monitoring presents a unique opportunity to curtail unnecessary treatment burdens. However, important considerations including, patients’ and professionals’ time, added paperwork, nurse education and training and inter-professional communication need to be explored. Further work is now needed to establish the clinical gains and patient outcomes of nurse-led medication monitoring.

Get access to the full text of this article

Ancillary